FDA Clearance Tracker · P040047
COAPTITE
Last checked: Nov 20, 2026Latest source record: Nov 10, 2005 (this decision)Source: openFDAMethods & limitations
Decided
Nov 10, 2005
Approved
Time to decision
336 days
Received Dec 9, 2004. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P040047
- Device name
- COAPTITE
- Applicant
- Merz North America, Inc.
- Applicant location
- Franksville, WI
- Received
- Dec 9, 2004
- Decided
- Nov 10, 2005
- Decision
- Approved
- Supplements
- 76 in FDA's data for this PMA. See them on the FDA record
Device type
- Device class
- Class III
- Specialty
- GI, Urology & NephrologyUrology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR COAPTITE. THE DEVICE IS INDICATED FOR SOFT TISSUE AUGMENTATION IN THE TREATMENT OF STRESS URINARY INCONTINENCE (SUI) DUE TO INTRINSIC SPHINCTER DEFICIENCY (ISD) IN ADULT FEMALES.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code LNM. The earliest in FDA's data is P900030, decided Sep 30, 1993.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Merz North America, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P250016 · Decided Jul 9, 2026 · 387 days after receipt
Device type: Implant, dermal, for aesthetic use (LMH) · General & Plastic Surgery
P250020 · Decided May 19, 2026 · 327 days after receipt
Device type: Implant, dermal, for aesthetic use (LMH) · General & Plastic Surgery
- RADIESSE® Injectable ImplantPMA supplement
P050052-S162 · Decided Mar 31, 2026 · 678 days after receipt · Panel Track
Device type: Implant, dermal, for aesthetic use (LMH) · General & Plastic Surgery
4 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.